Mammography is 'imperfect' test
October 14, 2011 By Liz Szabo in Cancer
For women today, turning 40 often brings birthday cake and candles. But it also brings a question: Should I get a mammogram?
Until two years ago, medical groups largely agreed women should get annual mammograms beginning at age 40. In 2009, the U.S. Preventive Services Task Force, a group of doctors who evaluate screening tests, broke ranks by encouraging women to talk to their doctors and make up their own minds.
Yet the debate continues. While few dispute the facts about mammograms, they often disagree on how women should act on results, says Otis Brawley, chief medical officer at the American Cancer Society.
For women in their 40s, mammograms reduce the risk of dying from breast cancer by about 15 percent, he says. But mammograms miss some cancers and raise false alarms about others, causing women to go through unnecessary follow-up tests, he says. ''We're saying, 'Mammography is a terribly imperfect test, but we're recommending women get it,''' Brawley says. ''The task force was saying, 'Mammography is a terribly imperfect test, and women have to make a decision about whether to get it in their 40s.' "
Barbara Monsees of the American College of Radiology still believes all women 40 and older need mammograms. That's because 75 percent of women with breast cancer have no known risk factors, she says.
But mammograms offer very different benefits, depending on a woman's age, says surgeon Susan Love, author of "Dr. Susan Love's Breast Book." In young women, breast cancers often grow too fast for mammograms to catch, appearing in between annual screenings, Love says.
Most women sharply overestimate both their risk of breast cancer and the benefits of mammograms, says Lisa Schwartz, a physician and researcher at the VA Outcomes Research Center in White River Junction, Vt. In a population of 10,000 women who are 40 years old, about 35 will die of breast cancer within 10 years. Getting a mammogram helps trim those odds, but only a little, saving five lives per 10,000. ''It's not like we want to deprive young women of their God-given right to be radiated,'' Love says. ''It just doesn't work that well for them.''
Schwartz says mammograms' benefits must be balanced against their risks. In a group of 10,000 women screened with mammograms, up to 2,000 will undergo an unnecessary biopsy, and up to 50 will get unnecessary treatment because a mammogram detects a slow-growing tumor of a type that would never prove life-threatening, she says. ''The cancers that screening is really best at finding are the 'good' ones that are never going to kill you anyway,'' Love says.
An estimated 1 percent to 10 percent of breast cancers are likely non-life-threatening, according to an analysis by oncologist Ellen Warner published in September in the New England Journal of Medicine.
Because doctors can't tell which breast tumors are destined to be life-threatening, they advise removing all of them, Love says. Yet therapies such as surgery, radiation, chemo and long-term hormone pills can mean serious, long-term side effects, says Warner.
Many women feel pressure to get mammograms; it's seen as the ''responsible'' thing to do, Schwartz says. ''Women don't want to (skip screening, then) feel like, 'Now I have this terrible cancer and it's all my fault.' ''
(c)2011 USA Today
Distributed by MCT Information Services
-
New national poll: 89 percent of women said mammograms vital to their health
Sep 27, 2011 |
not rated yet |
0
-
Doctors, women should spend more time discussing mammograms
Aug 09, 2011 |
not rated yet |
0
-
Study suggests mammograms under 50 if family risk
Nov 18, 2010 |
not rated yet |
0
-
Mammography use among women younger than 40 years old differ between minority populations
Dec 08, 2009 |
not rated yet |
0
-
ACR, SBI support updated ACOG recommendations that women begin annual mammograms at age 40
Jul 20, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Genetic diversity within tumors predicts outcome in head and neck cancer
A new measure of the heterogeneity – the variety of genetic mutations – of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer. In the May 20 issue ...
Cancer
21 minutes ago |
not rated yet |
0
Molecular marker from pancreatic 'juices' helps identify pancreatic cancer
Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis—two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic ...
Cancer
41 minutes ago |
not rated yet |
0
New smartphone application improves colonoscopy preparation
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
Cancer
May 19, 2013 |
not rated yet |
0
Research examines new methods for managing digestive health
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
Cancer
May 19, 2013 |
not rated yet |
1
New colonoscope provides ground-breaking view of colon
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
Cancer
May 18, 2013 |
5 / 5 (2) |
0
Blame your parents for bunion woes
A novel study reports that white men and women of European descent inherit common foot disorders, such as bunions (hallux valgus) and lesser toe deformities, including hammer or claw toe. Findings from the Framingham Foot ...
Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak
Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics.
Treatment of sleep apnea improves glucose levels in prediabetes
Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference in ...
Commonly used catheters double risk of blood clots in ICU and cancer patients
Touted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications.
ER docs are key to reducing health care costs
Emergency physicians are key decisionmakers for nearly half of all hospital admissions, highlighting a critical role they can play in reducing health care costs, according to a new report from the RAND Corporation.
New theory on genesis of osteoarthritis comes with successful therapy in mice
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
Oct 16, 2011
Rank: not rated yet